179 related articles for article (PubMed ID: 34177808)
41. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
Brubaker PL; Lee YC; Drucker DJ
J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
[TBL] [Abstract][Full Text] [Related]
42. Glucagon-like immunoreactivity in hypothalamic neurons of the rat.
Salazar I; Vaillant C
Cell Tissue Res; 1990 Aug; 261(2):355-8. PubMed ID: 2401007
[TBL] [Abstract][Full Text] [Related]
43. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.
Orskov C; Holst JJ; Knuhtsen S; Baldissera FG; Poulsen SS; Nielsen OV
Endocrinology; 1986 Oct; 119(4):1467-75. PubMed ID: 3530719
[TBL] [Abstract][Full Text] [Related]
44. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
Ohneda A; Ohneda M
Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
[TBL] [Abstract][Full Text] [Related]
45. Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells.
Fiocca R; Rindi G; Capella C; Grimelius L; Polak JM; Schwartz TW; Yanaihara N; Solcia E
Regul Pept; 1987 Jan; 17(1):9-29. PubMed ID: 2882565
[TBL] [Abstract][Full Text] [Related]
46. The forgotten members of the glucagon family.
Bataille D; Dalle S
Diabetes Res Clin Pract; 2014 Oct; 106(1):1-10. PubMed ID: 25115338
[TBL] [Abstract][Full Text] [Related]
47. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing.
Mojsov S; Heinrich G; Wilson IB; Ravazzola M; Orci L; Habener JF
J Biol Chem; 1986 Sep; 261(25):11880-9. PubMed ID: 3528148
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical studies on glucagon, glicentin and pancreatic polypeptide in human stomach: normal and pathological conditions.
Tsutsumi Y
Histochem J; 1984 Aug; 16(8):869-83. PubMed ID: 6207142
[TBL] [Abstract][Full Text] [Related]
49. Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2.
Damholt AB; Buchan AM; Holst JJ; Kofod H
Endocrinology; 1999 Oct; 140(10):4800-8. PubMed ID: 10499540
[TBL] [Abstract][Full Text] [Related]
50. Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas.
Thim L; Moody AJ
Biochim Biophys Acta; 1982 May; 703(2):134-41. PubMed ID: 7082677
[No Abstract] [Full Text] [Related]
51. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats.
Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL
Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813
[TBL] [Abstract][Full Text] [Related]
52. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat.
Fothergill LJ; Ringuet MT; Sioras E; Hunne B; Fazio Coles TE; Martins PR; Furness JB
Cell Tissue Res; 2019 Feb; 375(2):359-369. PubMed ID: 30259122
[TBL] [Abstract][Full Text] [Related]
53. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide.
Rouillé Y; Martin S; Steiner DF
J Biol Chem; 1995 Nov; 270(44):26488-96. PubMed ID: 7592866
[TBL] [Abstract][Full Text] [Related]
54. Response of plasma glicentin to fat ingestion in piglets.
Ohneda A; Takahashi H; Maruyama Y
Diabetes Res Clin Pract; 1987; 3(2):103-9. PubMed ID: 3552536
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
Drucker DJ; Lee YC; Asa SL; Brubaker PL
Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
[TBL] [Abstract][Full Text] [Related]
56. The peculiar processing of pancreatic hormone glucagon seen in traumatized patients.
Tanjoh K; Moriya T; Kinoshita K
Hepatogastroenterology; 2010; 57(99-100):620-4. PubMed ID: 20698238
[TBL] [Abstract][Full Text] [Related]
57. Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon.
Dey A; Lipkind GM; Rouillé Y; Norrbom C; Stein J; Zhang C; Carroll R; Steiner DF
Endocrinology; 2005 Feb; 146(2):713-27. PubMed ID: 15528303
[TBL] [Abstract][Full Text] [Related]
58. Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat.
Sasaki M; Fitzgerald AJ; Mandir N; Sasaki K; Wright NA; Goodlad RA
Aliment Pharmacol Ther; 2001 Oct; 15(10):1681-6. PubMed ID: 11564010
[TBL] [Abstract][Full Text] [Related]
59. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
60. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas.
Philippe J; Mojsov S; Drucker DJ; Habener JF
Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
